Zhuo Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhuo Huang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Charles Skarbek
Laboratory for Vascular Translational Science, INSERM U1148, Paris, France
1 shared publication - Jean Sénémaud
Department of Vascular Surgery, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France; Université Paris-Est Créteil, Créteil, France; Laboratory for Vascular Translational Science, INSERM U1148, Paris, France
1 shared publication - Joseph Touma
Department of Vascular Surgery, Henri Mondor University Hospital, Assistance Publique—Hopitaux de Paris, 1 Rue Gustave Eiffel, 94000 Créteil, France
1 shared publication - Pascal Desgranges
Department of Vascular and Endovascular Surgery, Henri Mondor University Hospital, Créteil, France
1 shared publication - Romain Gallet
Cedars-Sinai Heart Institute, Los Angeles, CA
1 shared publication - Yulin Li
Emergency Department, Pitié-Salpêtière Hospital, Assistance Publique—Hôpitaux de Paris, 75013 Paris, France
1 shared publication
Latest Publications
- Open Access
- 21 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 47
Evolution of Coronary Stents: From Birth to Future Trends
Coronary artery disease (CAD) remains one of the leading causes of mortality worldwide, affecting more than 300 million people. Over the past two decades, percutaneous coronary intervention (PCI) has become the cornerstone of CAD treatment, involving the implantation of coronary stents. This review clarifies how coronary stents emerged, evolved, and ultimately reshaped modern interventional cardiology. Beginning with balloon angioplasty and progressing through bare-metal and drug-eluting stents, we show how each advancement solved key clinical shortcomings—dramatically reducing restenosis, thrombosis, and repeat revascularization. We further review the major technological advances driving modern stent development, such as biodegradable alloys and biomimetic coatings. We also highlight the remaining challenges, including long-term stability, manufacturing complexity, and limited translational readiness. Together, these elements support our central thesis: that the historical evolution of coronary stents is fundamental to understanding present PCI practice and to guiding the next phase of device innovation.
- 21 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 47
Open AccessEvolution of Coronary Stents: From Birth to Future Trends
Coronary artery disease (CAD) remains one of the leading causes of mortality worldwide, affecting more than 300 million people. Over the past two decades, percutaneous coronary intervention (PCI) has become the cornerstone of CAD treatment, involving the implantation of coronary stents. This review clarifies how coronary stents emerged, evolved, and ultimately reshaped modern interventional cardiology. Beginning with balloon angioplasty and progressing through bare-metal and drug-eluting stents, we show how each advancement solved key clinical shortcomings—dramatically reducing restenosis, thrombosis, and repeat revascularization. We further review the major technological advances driving modern stent development, such as biodegradable alloys and biomimetic coatings. We also highlight the remaining challenges, including long-term stability, manufacturing complexity, and limited translational readiness. Together, these elements support our central thesis: that the historical evolution of coronary stents is fundamental to understanding present PCI practice and to guiding the next phase of device innovation.